Inflation Reduction Act
Coverage of Inflation Reduction Act in the Nexus archive.
- Drug prices have declined sharply, and Trump is taking credit. The reason behind the drop is complex
Federal data reports that U.S. prescription drug prices fell 3.1% from a year ago, marking the steepest year-over-year drop since 1963. Although the White House credits these price declines to Trump's drug deals, experts note that other factors are potentially more significant contributors. These complex factors include Medicare negotiations allowed by the Inflation Reduction Act and increased market competition from generic or biosimilar drugs.
- Drug prices have declined sharply, and Trump is taking credit. The reason behind the drop is complex
Recent federal data shows that U.S. prescription drug prices declined 3.1% from a year ago, the steepest drop since 1963. While Donald Trump has taken credit for these drops through “most favored nation” deals, experts suggest other factors are equally significant. These contributors include competition from generic and biosimilar products, as well as policy changes like the Inflation Reduction Act's allowance for Medicare to negotiate drug costs.
- Drug prices have declined sharply, and Trump is taking credit. The reason behind the drop is complex
U.S. prescription drug prices declined 3.1% from a year ago, marking the steepest drop since 1963. Although President Donald Trump claims credit via 'most favored nation' deals, experts note the price reduction is complex. Contributing factors include Medicare's ability to negotiate costs through policies like the Inflation Reduction Act, and market competition fueled by generic and biosimilar drugs.
- Courts rule Trump administration can’t cancel $22B in climate grants
Federal courts ruled that the Trump administration illegally attempted to cancel environmental and clean energy grants totaling billions of dollars. Specifically, a federal judge ordered the Environmental Protection Agency to restore $1.6 billion in climate justice grants after finding it unlawful for the EPA to claw back the funds. Separately, an appeals court restricted the agency's ability to terminate over $20 billion in clean energy grants awarded to nonprofit groups.
- Courts rule Trump administration can’t cancel $22B in climate grants
Two courts ruled against the Trump administration's attempt to cancel climate grants, ordering the EPA to reinstate $22 billion in funding for environmental and climate justice programs. A federal appeals court blocked the termination of $20 billion in clean energy grants, while a district judge mandated the restoration of $1.6 billion in grants after finding the EPA's withdrawal unlawful.
- Courts rule Trump administration can’t cancel $22B in climate grants
Courts blocked the Trump administration from canceling $22 billion in climate grants, with rulings against the EPA's termination of $20 billion in clean energy grants and $1.6 billion in climate justice grants. A federal judge ruled the EPA must reinstate the funds, citing unlawful termination of Biden-era grants under the Inflation Reduction Act.
- Two courts block Trump bid to cancel $22B in climate grants
Two courts blocked the Trump administration’s attempt to cancel climate grants, ruling the EPA’s termination of $20 billion in clean energy grants and $1.6 billion in climate justice grants unlawful. The rulings require the EPA to reinstate funds awarded under the Biden-era Inflation Reduction Act, though the agency has requested a delay to appeal.
- A Key Belief About the 2024 Election Isn’t True
The article challenges the conventional view that the Inflation Reduction Act (IRA) failed to deliver political benefits for Democrats in the 2024 election. It argues that the law’s clean-energy tax credits spurred $185 billion in private investment, creating factories in communities like Lordstown, Ohio, and that key components of the law remain effective despite claims of its repeal.
- STAT+: The latest orphan drug exemptions may not be warranted, analysis finds
A new analysis questions the justification for expanded exemptions of orphan drugs from Medicare pricing negotiations under the Orphan Cures Act, which broadened protections for drugs with multiple rare disease indications. The law delays price negotiation timelines for these drugs, despite concerns they may not warrant such exemptions.
- Top Trump ally warns super PAC bankrolled by Dem billionaire is meddling in his GOP primary
A super PAC funded by billionaire Chris Larsen is spending over $2 million to oppose Rep. Andy Ogles in a GOP primary, citing his criticism of clean energy subsidies. The Invest in Tomorrow Coalition, which raised $6.7 million this year, supports Charlie Hatcher, Tennessee’s former commissioner of agriculture, against Ogles. Larsen, founder of Ripple, has donated $6 million to the PAC since February 2026 and previously supported Kamala Harris’s campaign.
- The Trump administration is ending a Medicare drug subsidy program. Here’s how it could affect costs
The Trump administration is ending a Medicare drug subsidy program initiated by the Biden administration in 2024, leading to potential 2027 premium increases for 25 million Medicare Part D beneficiaries. Federal officials claim the impact will be minimal, with most seeing less than a $10-per-month increase, while Democrats criticize the move as increasing healthcare costs for seniors.
- The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs
The Trump administration is ending a Medicare Part D subsidy program, which could lead to higher monthly costs for 25 million beneficiaries starting in 2027. The program, initially implemented by the Biden administration in 2024, offset prescription drug premiums. Federal officials claim the impact will be minimal, but Democrats criticize the move as increasing healthcare costs for seniors.
- The Trump administration is ending a Medicare drug subsidy program. Here's how it could affect costs
The Trump administration is ending a Medicare drug subsidy program that lowered prescription drug costs for 25 million seniors, leading to potential higher monthly premiums in 2027. The program, initially implemented by the Biden administration in 2024, was a response to the 2022 Inflation Reduction Act. Democrats criticized the decision as increasing costs for seniors, while CMS claims the impact will be minimal, with most beneficiaries seeing less than a $10 monthly increase.
- US emissions reductions fall short of Biden-era goals
The US is projected to reduce greenhouse gas emissions by 27-41% below 2005 levels by 2040, missing Biden-era goals. A Rhodium Group report highlights that Trump-era policies may lead to natural gas and renewable power competing through the 2030s, limiting power sector emissions cuts. A Columbia University analysis found Trump's One Big Beautiful Bill Act preserved 74% of planned clean energy capacity compared to Biden's Inflation Reduction Act.
- Obamacare enrollment declines in 49 states
Obamacare enrollment declined in 49 states following the expiration of federal subsidies, with New Mexico being the sole exception after using state funds to replace the aid. The Trump administration attributed part of the decline to fraudulent enrollments, while KFF linked it to the loss of pandemic-era subsidies.
- Obamacare enrollment declines in 49 states
Obamacare enrollment declined in 49 states due to expired federal subsidies, with New Mexico being the only exception where state funds replaced the aid. The Trump administration attributed past enrollment growth to fraud, while KFF linked the recent drop to subsidy expiration.
- Obamacare enrollment declines in Pennsylvania and 48 other states
Obamacare enrollment declined in 49 states following the expiration of federal subsidies, with New Mexico being the only state to fully replace the aid using state funds. The Trump administration attributed prior enrollment growth to fraudulent activity, while KFF linked the decline to subsidy expiration.
- Obamacare enrollment declines in 49 states
Obamacare enrollment declined in 49 states due to expired federal subsidies, with New Mexico being the only exception where enrollment increased after using state funds to replace subsidies. The Trump administration attributed past enrollment growth to fraud, while KFF linked the recent drop to subsidy expiration.
- Biden’s climate law is dead. The energy transition might not be.
The Inflation Reduction Act, a major U.S. climate law, was repealed by a tax reform bill signed by President Donald Trump, derailing emissions reduction goals. However, the energy transition continues partially as some solar and wind projects proceed without subsidies, though clean energy development has slowed.
- Why heat pumps are still so hot in the US
Heat pump sales in the US have doubled over 15 years and outpaced natural-gas furnaces by 32% in Q1 2026, despite the end of a key tax credit in 2025. The appliances are efficient, can decarbonize buildings, and their sales have continued to rise post-tax credit, following seasonal trends.
- Healey rolls out $75M loan funds for municipal infrastructure
Governor Maura Healey announced two new revolving loan programs, Build for Mass and the Green Loan Program, offering low-interest financing for municipal infrastructure and clean energy projects. The $75 million initiative aims to address funding gaps, leverage federal resources, and support projects like climate resilience, water infrastructure, and clean energy installations.
- Luria to face Democratic challengers before a potential rematch with Kiggans in 2nd District
Four Democratic candidates will compete in Virginia's 2nd Congressional District primary on Aug. 4 to challenge Republican incumbent Jennifer Kiggans. The district, described as politically purple and a key contest for congressional control, includes candidates like former representative Elaine Luria and others advocating for accountability and policy reforms.
- SEN JEAN SHAHEEN: One immediate way Congress can ease families' insulin costs
Senator Jean Shaheen highlights the need to cap insulin costs for Americans, citing a bipartisan bill to limit monthly expenses to $35. The Inflation Reduction Act successfully reduced Medicare beneficiaries' insulin costs, but millions with private insurance still face high expenses. A Mississippi family's $194 monthly insulin cost for their young son underscores the ongoing issue.
- Utah senator: AZ it will forfeit millions in conservation aid if it sues over Colorado River water
U.S. Senator Mike Lee warned Arizona, California, and Nevada that they risk losing $354 million in conservation aid if they pursue litigation over Colorado River water management. The funds, from the 2022 Inflation Reduction Act, expire in September, and Lee urged states to resolve disputes over water allocation instead of engaging in legal battles.
- For first time, Americans are getting more of their electricity from solar than coal
Solar energy provided 12.8% of U.S. electricity in May, surpassing coal's 12.2% for the first time on record. Political efforts, including the 'One Big Beautiful Bill Act' and President Trump's coal industry funding, aim to counter renewable energy growth despite solar's rising share. Coal generation remains volatile but shows a slight monthly increase.
- Trump's DOE restarts energy rebate program with dumb conditions
The Department of Energy under Trump has restarted an energy rebate program but removed rebates for switching from fossil fuels to electricity and eliminated diversity, equity, and inclusion considerations. This follows legal challenges after Trump’s executive order halted funding from Biden’s Inflation Reduction Act, which a coalition of states successfully contested, leading to a March 2025 injunction to restore funds.
- Trump nixes rebates for switching from gas to electric appliances
The Trump administration has ended rebates for switching to electric appliances by reinterpreting a program under the 2022 Inflation Reduction Act. The Energy Department issued guidance changing the eligibility criteria for cash back incentives tied to high-efficiency electric home purchases.
- Sunrise Movement Backs Saikat Chakrabarti, Progressive Firebrand Behind the Green New Deal
The Sunrise Movement endorsed Saikat Chakrabarti, a former chief of staff to Rep. Alexandria Ocasio-Cortez and architect of the Green New Deal, for California’s 11th Congressional District. Chakrabarti, a progressive firebrand, faces Democratic rivals in a primary to succeed former House Speaker Nancy Pelosi, with support from figures like Reps. Rashida Tlaib and Ilhan Omar.
- Khanna torches Democrats for running 'status quo' candidates, admits working-class voters were ‘shafted’
Rep. Ro Khanna criticized Democrats for failing to connect with working-class voters by running 'status quo establishment candidates' and acknowledged systemic economic inequality. He referenced a DNC report highlighting the party's struggles with messaging and economic policy, defending DNC Chair Ken Martin despite calls for his resignation.
- Global investments in clean tech manufacturing drop
Global investments in clean technology manufacturing dropped 42% to $155 billion in 2025 after peaking in 2023, with significant declines in China and the US. China's decline reflects market oversupply from state support, while the US decline is more concerning as it occurs before planned investments materialize. Washington's rollback of clean energy incentives and trade restrictions on Chinese imports, along with policy unpredictability, have deterred Chinese companies from US manufacturing investments.